Calcitropic hormones, bone turnover, and lead exposure among female smelter workers

Archives of Environmental and Occupational Health

Volumn 60, Issue 4, 2005, Pages 195-204

  Potula, Vijayalakshmi ^a,b   Henderson, Alden ^a   Kaye, Wendy ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Bone turnover; Calcitropic hormones; Lead exposure

Indexed keywords

CADMIUM; CALCITRIOL; CALCIUM ION; DEOXYPYRIDINOLINE; HORMONE; LEAD; OSTEOCALCIN; PARATHYROID HORMONE; POTASSIUM; PYRIDINOLINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BONE TURNOVER; CALCIUM BLOOD LEVEL; EMPLOYMENT; FEMALE; FEMALE WORKER; HORMONE BLOOD LEVEL; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MINING; OCCUPATIONAL EXPOSURE; OSTEOLYSIS; POSTMENOPAUSE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SMELTER; TIBIA; URINE LEVEL; X RAY FLUORESCENCE;

EID: 33845736924     PISSN: 19338244     EISSN: None     Source Type: Journal    
DOI: 10.3200/AEOH.60.4.195-204     Document Type: Article

References (57)

1. Hu H, Aro A, Payton M, et al. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA. 1996;275: 1171-1176.
2. Korrick S, Hunter D, Rotnitzky A, Hu H, Speizer F. Lead and hypertension in a sample of middle-aged women. Am J Public Health. 1999;89:330-335.
3. Payton M, Riggs KM, Spiro A III, Weiss ST, Hu H. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol. 1998;20:19-27.
4. Stewart WF, Schwartz BS, Simon D, Bolla KI, Todd AC, Links J. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology. 1999;52:1610-1617.
5. Gonzalez-Cossio T, Peterson KE, Sanin LH, et al. Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics. 1997;100:856-862.
6. Silbergeld EK, Schwartz J, Mahaffey K, Lead and osteoporosis: mobilization of lead from bone in women. Environ Res. 1988;47:79-94.
7. Hu H. Bone lead as a new biologic marker of lead dose: recent findings and implications for public health. Environ Health Perspect. 1998;106(suppl 4):961-967.
8. Rabinowitz MB. Toxicokinetics of bone lead. Environ Health Perspect. 1991;91:33-37.
9. Bronner F. Bone and calcium homeostasis. Neurotoxicology. 1992;13: 775-782.
10. Pounds JG. Effects of lead intoxication on calcium homeostasis and calcium-mediated cell function: a review. Neurotoxicology. 1984;5: 295-332.
11. Brot C, Jorgensen N, Madsen OR, Jensen LB, Sorensen OH. Relationships between BMD, serum 1, 25-dihydroxyvitamin D metabolites and calcium phosphorus intake in healthy perimenopausal women. J Intern Med. 1999;245:509-516.
12. Vega MM, Solorzano JC, Salinas JV. The effects of dietary calcium during lactation on lead in bone mobilization: implications for toxicology. Hum Exp Toxicol. 2002;21:409-414.
13. Norman AW, Litwack G. Hormones. 2nd ed. San Diego, CA: Academic Press;1997.
14. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178-208.
15. Kristal-Boneh E, Froom P, Yerushalmi N, Harari G, Ribak J. Calciotropic hormones and occupational lead exposure. Am J Epidemiol. 1998;147:458-163.
16. Mason HJ, Somervaille LJ, Wright AL, Chettle DR, Scott MC. Effect of occupational lead exposure on serum 1, 25-dihydroxyvitamin D levels. Hum Exp Toxicol. 1990;9:29-34.
17. Review of Worker Exposures and Health Evaluations at the Bunker Hill Facility, Kellogg, Idaho. Washington, DC: US Environmental Protection Agency; 1975. BCI, Sections 1-5.
18. Agency for Toxic Substances and Disease Registry. Study of Female Former Workers at a Lead Smelter: An Examination of the Possible Association of Lead Exposure With Decreased Bone Density and Other Health Outcomes. Atlanta, GA: Centers for Disease Control and Prevention; 1997. US Dept of Health and Human Services publication PB97-144844.
19. Todd AC, McNeill FE, Fowler BA. In vivo X-ray fluorescence of lead in bone. Environ Res. 1992;59:326-335.
20. Gordon CL, Chettle DR, Webber CE. An improved instrument for the in vivo detection of bone-lead. Br J Ind Med. 1993;50:637-641.
21. Stokes L, Letz R, Gerr F, et al. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med. 1998;55:507-516.
22. Burger DE, Milder FL, Morsillo PR, Adams BB, Hu H. Automated bone-lead analysis by K-x-ray fluorescence for the clinical environment. Basic Life Sci. 1990;55:287-292.
23. Hu H, Milder FL, Burger DE. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposure. Arch Environ Health. 1990;45:335-341.
24. Kim R, Aro A, Rotnitzky A, Amarasiriwardena C, Hu H. K x-ray fluorescence measurements of bone-lead concentration: the analysis of low-level data. Phys Med Biol. 1995;40:1475-1485.
25. Nash D, Magder L, Lustberg M, et al. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women [comment]. JAMA. 2003;289:1523-1532.
26. Estrada RO, Wyatt CJ. Relationship of deoxypyridinole excretion with bone density, serum estradiol and years of postmenopause in Mexican postmenopausic women. Arch Latinoamericanos Nutr. 2004;54: 408-112.
27. Nash D, Magder LS, Sherwin R, Rubin RJ, Silbergeld EK. Bone density-related predictors of blood lead level among peri- and post-menopausal women in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2004;160:901-911.
28. Gulson B, Mizon K, Smith H, et al. Skeletal lead release during bone resorption: effect of bisphosphonate treatment in a pilot study. Environ Health Perspect. 2002;110:1017-1023.
29. Tsaih SW, Korrick S, Schwartz J, et al. Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study. Environ Health Perspect. 2001; 109:995-999.
30. Osterode W, Reining G, Manner G, Jager J, Vierhapper H. Increased lead excretion correlates with desoxypyridinoline crosslinks in hyperthyroid patients. Thyroid. 2000;10:161-164.
31. Osterode W, Zettinig G, Potzi C. Manner G. Increased lead excretion in hypothyroid patients after levothyroxine medication. J Toxicol Environ Health. 2002;65(pt A):649-654.
32. Tsaih SW, Korrick S, Schwartz J, et al. Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study. Environ Health Perspect. 2001; 109:995-999.
33. Hense HW, Filipiak B, Novak L, Stoeppler M. Non-occupational determinants of blood lead concentrations in a general population. Int J Epidemiol. 1992;21:753-762; erratum, 1199.
34. Harlan WR. The relationship of blood lead levels to blood pressure in the US population. Environ Health Perspect. 1988;78:9-13.
35. Hu H, Hashimoto D, Besser M. Levels of lead in blood and bone of women giving birth in a Boston hospital. Arch Environ Health. 1996; 51:52-58.
36. Watanabe H, Hu H, Rotnitzky A. Correlates of bone and blood lead levels in carpenters. Am J Ind Med. 1994;26:255-264.
37. Hernandez-Avila M, Gonzalez-Cossio T, Palazuelos E, et al. Dietary and environmental determinants of blood and bone lead levels in lactating postpartum women living in Mexico City. Environ Health Perspect. 1996;104:1076-1082.
38. Somervaille LJ, Chettle DR, Scott MC, et al. In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med. 1988;45:174-181.
39. Hu H, Milder F, Burger DE. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposures. Arch Environ Health. 1990;45:335-341.
40. Kosnett MJ, Becker CE, Osterloh JD, Kelly TJ, Pasta DJ. Factors influencing bone lead concentration in a suburban community assessed by non-invasive K X-ray fluorescence. JAMA. 1994;271:197-203.
41. Somervaille LJ, Chettle DR, Scott MC. In vivo measurement of lead in bone using X-ray fluorescence. Phys Med Biol. 1985;30: 929-943.
42. Webber CE, Chettle DR, Bowins RJ, et al. Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect. 1995;103:1150-1153.
43. Hu FB, Grodstein F. Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence. Am J Cardiol. 2002;90:26F-29F.
44. Nash D, Silbergeld E, Magder L, Stolley P. Menopause, hormone replacement therapy (HRT), and blood lead levels among adult women from NHANES III, 1988-1994. Am J Epidemiol. 1998;147:S93. Abstract.
45. Richelson LS, Wahner HW, Melton LJ III, Riggs BL. Relative contributions of aging and estrogen deficiency to post-menopausal bone loss. N Engl J Med. 1984;311:1273-1275.
46. Osterloh JD, Clark OH. Effects of hyperparathyroidism on blood lead concentrations in man. Environ Res. 1993;62:1-6.
47. Goldman RH, White R, Kales SN, Hu H. Lead poisoning from mobilization of bone stores during thyrotoxicosis. Am J Ind Med. 1994; 25:417-124.
48. Six KM, Goyer RA. Experimental enhancement of lead toxicity by low dietary calcium. J Lab Clin Med. 1970;76:933-940.
49. Koo WW, Succop PA, Bornschein RL, et al. Serum 1, 25-dihydroxyvitamin D metabolites and bone mineralization in young children with chronic low to moderate lead exposure. Pediatrics. 1991;87:680-687.
50. Fullmer CS. Dietary calcium levels and treatment interval determine the effects of lead ingestion on plasma vitamin D concentration in chicks. J Nutr. 1995;125:1328-1333.
51. Smith CM, DeLuca HF, Tanaka Y, Mahaffey KR. Effect of lead ingestion on functions of vitamin D and its metabolites. J Nutr. 1981; 111:1321-1329.
52. Sorrell M, Rosen JF. Interactions of lead, calcium, vitamin D, and nutrition in lead-burdened children. Arch Environ Health. 1977;32: 160-164.
53. Rosen JF, Chesney RW, Hamstra A, DeLuca HF, Mahaffey KR. Reduction in 1,25-dihydroxy vitamin D in children with increased lead absorption. N Engl J Med. 1980;302:1128-1131.
54. Mahaffey KR, Rosen JF, Chesney RW, Peeler JT, Smith CM, DeLuca HF. Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr. 1982;35:1327-1331.
55. Chalkley SR, Richmond J, Barltrop D. Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium [see comment]. Occup Environ Med. 1998;55:446-452.
56. Mason HJ, Somervaille LJ, Wright AL, Chettle DR, Scott MC. Effect of occupational lead exposure on serum 1,25-dihydroxy vitamin D levels. Hum Exp Toxicol. 1990;9:29-34.
57. 2+ on the structure and hydroxyapatite binding properties of osteocalcin. Biochim Biophys Acta. 2001;1535:153-163.